1.Hepatoprotective effect of Lingzhi extract on CCl4-induced hepatic lesion
Journal of Medicinal Materials - Hanoi 2005;10(3):88-92
Study on hepatoprotective effects of lingzhi extract on CCl4-induced hepatic lesion, lingzhi formulation produced by OPC Company which reached standards at basic level. Lingzhi dry powder was prepared with distilled water to make liquid extract with concentrations of 15% (15g dry extract/100ml water), 30% and 75%. These liquid extracts were used to test hepatoprotective effects. With low dose CCl4 (0,25%) induced hepatic toxication, 15%, 30% and 75% lingzhi extracts showed hepatoprotective effect. However, with high dose CCl4 (1%), only 30% lingzhi extract showed clear and stable hepatoprotective effects. Experimental trials on hepatic diseases as well as on hepatoprotective medications should provide necessary information on physiopathological characteristics and medicinal therapies
Drugs, Chinese Herbal
;
Liver
3.Q-marker prediction of Magnoliae Officinalis Cortex before and after "sweating".
Chang LIU ; Xiao WANG ; Fang LIU ; Hui-Ling HU ; Shao-Yang LIU ; Xiao LUO ; Chao-Mei FU ; Bin DENG
China Journal of Chinese Materia Medica 2021;46(11):2686-2690
Magnoliae Officinalis Cortex, a common Chinese medicinal in clinic, should undergo "sweating" process in producing area according to Chinese Pharmacopoeia, which affects its genuineness and quality. In light of the concept and research mode of quality marker(Q-marker) for decoction pieces, the active components of Magnoliae Officinalis Cortex pieces which altered significantly before and after "sweating" were identified in this study. The main pharmacodynamic material basis was clarified by pharmacodynamic, pharmacokinetic and drug property research, followed by the prediction of Q-markers of Magnoliae Officinalis Cortex before and after "sweating", for better improving its quality standard.
Drugs, Chinese Herbal
;
Magnolia
4.Bibliometric analysis and quality assessment of clinical evidence on Xiaotong Tiegao.
Sai-Nan FANG ; Bao-Jun WEI ; Chuan-Qi TANG ; Jian-Min WEN ; Xue BAI ; Si-Hong YANG ; Ying-Jie GUAN ; Yan-Ming XIE ; Wei CHEN
China Journal of Chinese Materia Medica 2019;44(20):4360-4365
Many clinical studies on Cheezheng Xiaotong Tiegao have been accumulated since it was launched in 1993,but they have not been comprehensively analyzed and evaluated. This study systematically retrieved relevant studies in six databases at home and abroad as of December 2017. This study analyzed the statistics of the included studies in several aspects,including publication time,region,fund,disease category and type of study. In this study,various tools were used to evaluate the methodological quality of included studies,such as the Cochrane collaboration's tool for assessing the risk of bias in randomized trials,MINORS,IHE,AMSTAR2.The results showed that the literatures were mainly published from 2010 to 2011,and a total of 28 projects were financially supported.The most involved disease was arthropathy. The randomized controlled trials were the majority in the included studies,but the quality was low,and most of the literatures didn't report the allocation concealment and blinding. This study comprehensively reflected the current situations and shortcomings of the clinical studies of Cheezheng Xiaotong Tiegao,and put forward several suggestions,in the expectation of providing a reference for the future clinical research direction of Cheezheng Xiaotong Tiegao.
Bibliometrics
;
Drugs, Chinese Herbal
5.Elaboration of protocol in dosage of ferulic acid in Radix angelicae sinensis by HPLC
Pharmaceutical Journal 2005;348(4):21-24
The extracted and purified ferulic acid residue from Radix angelicae sinensis was quantified by an established HPLC system composed of the following conditions: reversed phase column C-18 Purosphere 4.6mm 1D x 250 mm (5mm); mobile phase: acetonitrile/potassium dihydrophosphate 10 mM/L (15/85); pH: 4.5; flow rate: 1.2 mL/min; column temperature: 30oC. The results showed that the method can meet the following criteria: Rs > 1.5, RSD < 2%, N > 1 000, Tf in the range 0.8-1.2
Coumaric Acids
;
Drugs
;
Chinese Herbal
6.Review on recent development of antitumor agents from Chinese herbal medicines
Journal of Medicinal Materials - Hanoi 2005;10(2):35-40
Besides low molecular compounds against morphological and cytotoxic change that were extracted from Chinese herbal medicines, some high molecular compounds have been extracted and used for treatment of malignant disease. Among which, polysaccharides and ribosome-inactivating proteins are specially noticed. Polysaccharides from fungal and high-class plants with immunostimulation effects have been tested in experimentation and in clinical. Ribosome-inactivating proteins are a group of proteins inhibited standard protein synthesis in nucleus by attacking 28S ribosome RNA. These substances have been tested in experimental and clinical trials for treating tumor by single compound and combined with antibodies
Drugs, Chinese Herbal
;
Antineoplastic Agents
7.Isolation and structure determination of coumarine from extract of Eupatorium chinese L
Pharmaceutical Journal 2003;326(6):12-13
Eupatorium chinese L. is an indegenous plant using in the folk medicine of Vietnam. From the ethanol extract and petroleum – ether extract of aerial parts of this plant a coumarin was isolated. It’s structure was identified by MS, 1H-NMR, 13C-NMR and 13C-DEPT methods
Coumarins
;
Drugs, Chinese Herbal
;
Medicine
8.A accurate identification method for Chinese materia medica--systematic identification of Chinese materia medica.
Xue-Yong WANG ; Cai-Li LIAO ; Si-Qi LIU ; Chun-Sheng LIU ; Ai-Juan SHAO ; Lu-Qi HUANG
China Journal of Chinese Materia Medica 2013;38(9):1451-1454
This paper put forward a more accurate identification method for identification of Chinese materia medica (CMM), the systematic identification of Chinese materia medica (SICMM) , which might solve difficulties in CMM identification used the ordinary traditional ways. Concepts, mechanisms and methods of SICMM were systematically introduced and possibility was proved by experiments. The establishment of SICMM will solve problems in identification of Chinese materia medica not only in phenotypic characters like the mnorphous, microstructure, chemical constituents, but also further discovery evolution and classification of species, subspecies and population in medical plants. The establishment of SICMM will improve the development of identification of CMM and create a more extensive study space.
Drugs, Chinese Herbal
;
Materia Medica
9.Evaluation of balanced release of complex components of Chuanping sustained tablets based on fingerprint.
Yan-Qu CAI ; Jian CHEN ; Ji-Fu XIE ; Jin-Zhen CHAI ; Jing LIU ; Qing-Ting PENG ; Sheng-Shan ZHU
China Journal of Chinese Materia Medica 2013;38(9):1360-1365
To combine fingerprint and drug release rate in vitro, in order to study in vitro release of complex components of Chuanping sustained tablets, compound traditional Chinese medicine preparation. A qualitative determination of the characteristic peaks of the compound preparations were conducted by the fingerprint. The results of the dissolution rate determination under different release conditions showed that the release of three index components (methamphetamine, pseudoephedrine and scopolamine) of Chuanping sustained tablets was less affected by gastrointestinal factors, with similarity factors being more than 80 with unknown component release curves of three major characteristic peaks in the fingerprint. The qualitative determination proved that multiple components of the compound traditional Chinese medicine preparation was dissolved in vitro at similar rates, realizing the balanced release of complex components of the compound traditional Chinese medicine preparation. This study layed a theoretical and experimental basis for quality evaluation for the compound traditional Chinese medicine preparation.
Drugs, Chinese Herbal
;
chemistry
;
Tablets